| Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis J Li, B Zou, YH Yeo, Y Feng, X Xie, DH Lee, H Fujii, Y Wu, LY Kam, F Ji, ... The lancet Gastroenterology & hepatology 4 (5), 389-398, 2019 | 986 | 2019 |
| Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis Q Ye, B Zou, YH Yeo, J Li, DQ Huang, Y Wu, H Yang, C Liu, LY Kam, ... The lancet Gastroenterology & hepatology 5 (8), 739-752, 2020 | 760 | 2020 |
| 2019 Global NAFLD prevalence: a systematic review and meta-analysis MH Le, YH Yeo, X Li, J Li, B Zou, Y Wu, Q Ye, DQ Huang, C Zhao, ... Clinical Gastroenterology and Hepatology 20 (12), 2809-2817. e28, 2022 | 560 | 2022 |
| Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma YH Yeo, JS Samaan, WH Ng, PS Ting, H Trivedi, A Vipani, W Ayoub, ... Clinical and molecular hepatology 29 (3), 721, 2023 | 436 | 2023 |
| Effect of sarcopenia on survival in patients with cirrhosis: a meta-analysis X Tantai, Y Liu, YH Yeo, M Praktiknjo, E Mauro, Y Hamaguchi, ... Journal of hepatology 76 (3), 588-599, 2022 | 290 | 2022 |
| Multiplex PCR system for rapid detection of pathogens in patients with presumed sepsis–a systemic review and meta-analysis SS Chang, WH Hsieh, TS Liu, SH Lee, CH Wang, HC Chou, YH Yeo, ... PloS one 8 (5), e62323, 2013 | 288 | 2013 |
| Factors associated with rates of HBsAg seroclearance in adults with chronic HBV infection: a systematic review and meta-analysis YH Yeo, HJ Ho, HI Yang, TC Tseng, T Hosaka, HN Trinh, MS Kwak, ... Gastroenterology 156 (3), 635-646. e9, 2019 | 239 | 2019 |
| Prevalence, characteristics and mortality outcomes of obese, nonobese and lean NAFLD in the United States, 1999–2016 B Zou, YH Yeo, VH Nguyen, R Cheung, E Ingelsson, MH Nguyen Journal of internal medicine 288 (1), 139-151, 2020 | 211 | 2020 |
| Assessing the accuracy of responses by the language model ChatGPT to questions regarding bariatric surgery JS Samaan, YH Yeo, N Rajeev, L Hawley, S Abel, WH Ng, N Srinivasan, ... Obesity surgery 33 (6), 1790-1796, 2023 | 192 | 2023 |
| Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach MH Le, YH Yeo, B Zou, S Barnet, L Henry, R Cheung, MH Nguyen Clinical and molecular hepatology 28 (4), 841, 2022 | 174 | 2022 |
| Liberal versus restricted fluid resuscitation strategies in trauma patients: a systematic review and meta-analysis of randomized controlled trials and observational studies CH Wang, WH Hsieh, HC Chou, YS Huang, JH Shen, YH Yeo, HE Chang, ... Critical care medicine 42 (4), 954-961, 2014 | 141 | 2014 |
| Natural history and hepatocellular carcinoma risk in untreated chronic hepatitis B patients with indeterminate phase DQ Huang, X Li, MH Le, AK Le, YH Yeo, HN Trinh, J Zhang, J Li, C Wong, ... Clinical Gastroenterology and Hepatology 20 (8), 1803-1812. e5, 2022 | 115 | 2022 |
| Chronic hepatitis B prevalence among foreign‐born and US‐born adults in the United States, 1999‐2016 MH Le, YH Yeo, R Cheung, L Henry, AS Lok, MH Nguyen Hepatology 71 (2), 431-443, 2020 | 115 | 2020 |
| The epidemiology of NAFLD in Mainland China with analysis by adjusted gross regional domestic product: a meta-analysis Y Wu, QI Zheng, B Zou, YH Yeo, X Li, J Li, X Xie, Y Feng, CD Stave, Q Zhu, ... Hepatology international 14, 259-269, 2020 | 96 | 2020 |
| Sustained virologic response to direct-acting antiviral therapy in patients with chronic hepatitis C and hepatocellular carcinoma: a systematic review and meta-analysis F Ji, YH Yeo, MT Wei, E Ogawa, M Enomoto, DH Lee, E Iio, J Lubel, ... Journal of hepatology 71 (3), 473-485, 2019 | 95 | 2019 |
| Cure with interferon‐free direct‐acting antiviral is associated with increased survival in patients with hepatitis C virus‐related hepatocellular carcinoma from both east and west H Dang, YH Yeo, S Yasuda, CF Huang, E Iio, C Landis, DW Jun, ... Hepatology 71 (6), 1910-1922, 2020 | 82 | 2020 |
| Association between fatty liver and cirrhosis, hepatocellular carcinoma, and hepatitis B surface antigen seroclearance in chronic hepatitis B J Li, HI Yang, ML Yeh, MH Le, AK Le, YH Yeo, CY Dai, S Barnett, ... The Journal of Infectious Diseases 224 (2), 294-302, 2021 | 77 | 2021 |
| First-line Helicobacter pylori eradication therapies in countries with high and low clarithromycin resistance: a systematic review and network meta-analysis. WCY Yeo YH, Shiu SI, Ho HJ, Zou B, Lin JT, Wu MS, Liou JM, ... Gut, 2016 | 77* | 2016 |
| Ethnic influence on nonalcoholic fatty liver disease prevalence and lack of disease awareness in the United States, 2011–2016 MH Le, YH Yeo, R Cheung, VWS Wong, MH Nguyen Journal of Internal Medicine 287 (6), 711-722, 2020 | 75 | 2020 |
| Incidences and determinants of functional cure during entecavir or tenofovir disoproxil fumarate for chronic hepatitis B YC Hsu, ML Yeh, GLH Wong, CH Chen, CY Peng, M Buti, M Enomoto, ... The Journal of infectious diseases 224 (11), 1890-1899, 2021 | 71 | 2021 |
Chun-Ying WuTaipei Veterans General Hospital; National Yang-Ming UniversityBestätigte E-Mail-Adresse bei vghtpe.gov.tw